Get my own profile
Public access
View all102 articles
2 articles
available
not available
Based on funding mandates
Co-authors
David ToughGSKVerified email at gsk.com
emmanuel h demontVP, Head of Medicinal Chemistry and DMPKVerified email at apollotx.com
Uwe SchaeferSenior Research Associate, The Rockefeller UniversityVerified email at rockefeller.eduRobert J WatsonGSKVerified email at gsk.com
Frank S WalshCEO OssianixVerified email at ossianix.comTaylor, SPharmaron UKVerified email at sky.com
Paul Peter TakCandel Therapeutics, GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, AmsterdamVerified email at candeltx.com
Marcus BantscheffCellzome, a GSK companyVerified email at gsk.com
Gerard DrewesCellzome/GlaxoSmithKline R&DVerified email at gsk.com
Wouter de JongeProf of exp Gastroenterology, Amsterdam UMCVerified email at amsterdamumc.nl
Scott DewellSenior Director, Biodevelopment - CepheidVerified email at cepheid.com
kouzaridesUniversity of CambridgeVerified email at gurdon.cam.ac.uk
John B DavisUniversity of OxfordVerified email at cmd.ox.ac.ukSamuel RobsonProfessor of Genomics and BioinformaticsVerified email at port.ac.uk
Ivan MarazziCentre of Epigenetics and MetabolismVerified email at uci.edu
Brian HuntlyVerified email at cam.ac.uk
Michael T. McCabeVerified email at gsk.comIsabelle BecherEMBL HeidelbergVerified email at embl.de
Paul WilsonScientific Investigator GSKVerified email at gsk.com
Andrew J BannisterRetired Senior Research Associate, Gurdon Institute, University of CambridgeVerified email at cam.ac.uk